Athersys Investor Relations Material
Latest events
Investor Update
Athersys
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Athersys Inc
Access all reports
Athersys, Inc., through its subsidiary, Healios K.K., focuses on the research and development of MultiStem cell therapy to treat various diseases; and marketing and developing of MultiStem as an off-the-shelf cell therapy to treat acute myocardial infarction, acute respiratory distress syndrome, ischemic stroke, and traumatic brain injury. It also focuses on research and development activities for a range of therapeutic applications in other areas, including hematology, inflammatory bowel disease and other gastrointestinal disorders, liver disease and repair, anti-inflammation in support of wound healing applications, bone fracture repair, trauma/surgical care applications, oncology supportive care applications, diabetes mellitus, retinitis pigmentosa, and human immunodeficiency virus associated morbidities.
Key slides for Athersys Inc
Investor Presentation
Athersys Inc
Investor Presentation
Athersys Inc
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States